Romosozumab: A new anabolic arrow in quiver for management of osteoporosis
Author(s) -
Alok Singh,
Dhyuti Gupta
Publication year - 2020
Publication title -
acta medica international
Language(s) - English
Resource type - Journals
eISSN - 2349-0578
pISSN - 2349-0896
DOI - 10.4103/ami.ami_68_20
Subject(s) - medicine , osteoporosis , denosumab , teriparatide , strontium ranelate , raloxifene , sclerostin , adverse effect , intensive care medicine , bone mineral , cancer , wnt signaling pathway , biochemistry , chemistry , estrogen receptor , breast cancer , gene
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom